InvestorsHub Logo
Followers 47
Posts 3929
Boards Moderated 0
Alias Born 03/04/2012

Re: None

Sunday, 09/05/2021 9:03:14 PM

Sunday, September 05, 2021 9:03:14 PM

Post# of 403039
Recent Pro and Con arguments:

Pro:

Brilacidin has never failed a clinical trial

George Mason University’s Regional BioLab testing confirms stellar in vitro results of Brilacidin for Covid-19 and several other viruses

Received Fast Track Designation from FDA for PH II trial

Phase II International Trial results expected in September, with data lock any day now.

Brilacidin has shown three (3) MOAs in vitro to destroy Covid and has a selectivity index of 426

Company had about 10 million in the bank as of last Q

Biden administration just announced plans to spend $36B on the development of new vaccines and therapeutics.


Con:

CEO Leo hasn’t updated any other Brilacidin indications

CEO hasn’t released BOD meeting notes

CEO has neglected shareholder communications

CEO is diluting for “lifestyle reasons”

CEO's past behavior predicts future behavior

The CEO is posting on stock boards under an assumed name

This company is a scam just like all the other pink sheet stocks
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News